couter

BNXT.CNBioNxt Solutions Inc.

Health CarePharmaceuticals
Oct 14, 2026 — Emergency Capital Raise / Financing Facility
Chart by TradingView

The schedule

  • Wed14Oct

    Anticipated announcement of an equity offering or convertible debt facility to cure the working capital deficit.

  • Wed24Feb

    Expected milestone readout regarding BioNxt's alternative drug delivery or generic formulation platforms.

  • Fri26Feb

    Q3 results showing the initial aftermath of potential restructuring or financing efforts.

  • Wed28Apr

    Full-year 2026 financial results and 2027 operational guidance.

  • Fri28May
  • Fri27Aug

Past

  • Fri28Aug

    Expected Q2 2026 earnings report, with critical focus on balance sheet liquidity and going-concern status.